# PAQ Therapeutics

> Clinical-stage biotechnology company in Burlington, Massachusetts developing
> targeted protein degradation (TPD) medicines for KRAS-driven cancers. PAQ
> Therapeutics publishes no API, SDK, developer portal or machine-readable
> contract. This file is generated by API Evangelist from a public profile of
> the company; it is not published by PAQ Therapeutics.

## About

PAQ Therapeutics develops autophagy-based degrader chemistry that recruits the
cell's own natural degradation machinery to remove the KRAS oncoprotein rather
than inhibit it. KRAS mutations are present in roughly a quarter of human
tumors, concentrated in lung, colorectal and pancreatic cancer. The lead
program, PT0511, is a pan-KRAS degrader that dosed its first patient in a
Phase 1 trial in January 2026. Co-founders: Nan Ji (CEO) and Huaixiang Hao
(Head of Research); Andrew Krivoshik is Chief Medical Officer.

Headquarters: 100 Summit Drive, Suite 916, Burlington, MA 01803, United States.

## Company

- [PAQ Therapeutics](https://www.paqtx.com/): Corporate website — approach, technology, team, contact.
- [News & Media](https://www.paqtx.com/news-archive/): Dated company news archive.
- [News RSS](https://www.paqtx.com/feed/): RSS feed for the news archive.
- [LinkedIn](https://www.linkedin.com/company/paq-therapeutics): Company page.

## Legal

- [Privacy Policy](https://www.paqtx.com/privacy-policy/)
- [Terms and Conditions](https://www.paqtx.com/terms-and-conditions/)

## API surface

None. Probed 2026-08-26 against www.paqtx.com — the only host the company
operates. No api./developer./developers./docs./portal. subdomain resolves in
DNS. No OpenAPI, Swagger, GraphQL, AsyncAPI, gRPC or WSDL contract is
published. Every /.well-known/ discovery path returns 404. No first-party
package exists on npm or PyPI, and no GitHub organization matches the company.
There is no MCP server and no A2A agent card.

## Optional

- [Domain security probe](https://github.com/api-evangelist/paq-therapeutics/blob/main/security/paq-therapeutics-domain-security.yml): TLS/HSTS/DNSSEC/CAA/SPF/DMARC posture, probed 2026-08-26.
- [Well-known probe](https://github.com/api-evangelist/paq-therapeutics/blob/main/well-known/paq-therapeutics-well-known.yml): Recorded absence of every /.well-known/ discovery document.